Humalog Mix 50/50 Inj, 10ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue of the skin in the upper arm, thigh, buttocks, or stomach area. If you will be self-administering the injection, your doctor or nurse will instruct you on the proper technique.
Before use, this medication must be mixed according to the instructions provided by your doctor. Use the medication immediately after mixing. It is recommended to take the medication 15 minutes before a meal. Rotate the injection site each time to avoid tissue damage.
Important Administration Guidelines
Do not inject into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
The medication should appear cloudy and milky when ready to use. Do not use if the solution is clear or contains lumps.
Do not use if powder is stuck to the sides of the container or if the solution is leaking, has particles, or has changed color.
Safe Disposal and Storage
Dispose of used needles in a designated needle/sharp disposal box. Do not reuse needles or other items.
When the disposal box is full, follow local regulations for proper disposal.
Store unopened containers in the refrigerator. Do not freeze, and do not use if the medication has been frozen.
Diet, Exercise, and Missed Doses
Follow the diet and exercise plan recommended by your doctor.
Be aware of the steps to take if you miss a meal or do not eat as much as usual.
Do not mix this insulin with other types of insulin in the same syringe.
Do not draw the medication into a syringe and store it for future use.
This medication is not compatible with insulin pumps. If you have questions, consult your doctor.
Missed Dose Instructions
If you forget to take a dose, follow the plan discussed with your doctor.
* If you are unsure what to do in the event of a missed dose, contact your doctor for guidance.
Lifestyle & Tips
- Follow your prescribed diet plan and meal schedule consistently.
- Engage in regular physical activity as advised by your healthcare provider.
- Monitor your blood glucose levels regularly as instructed.
- Rotate injection sites to prevent skin problems like lipodystrophy.
- Carry a source of fast-acting sugar (e.g., glucose tablets, juice) to treat mild to moderate hypoglycemia.
- Inform all healthcare providers, including dentists, that you are using insulin.
Available Forms & Alternatives
Available Strengths:
- Humalog Insulin (vl-7510) 10ml
- Humalog Mix 75/25 Vial 10ml
- Humalog Cartridge 3ml
- Humalog Mix 50/50 Inj, 10ml
- Humalog Mix 50/50 Kwikpen Inj 3ml
- Humalog 100 U/ml Kwik Pen Inj 3ml
- Humalog Mix 75/25 Kwikpen Inj 3ml
- Humalog 100u/ml Vial 3ml
- Humalog 200 U/ml Kwikpen Inj 3ml
- Humalog Jr 100u/ml Kwikpnhalf Unit
- Humalog Tempo Pen 100u/ml Inj 3ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Some allergic reactions can be life-threatening.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An irregular heartbeat
Thick skin, pits, or lumps at the injection site
Swelling in the arms or legs
Shortness of breath
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures
If you experience any of these symptoms, call your doctor right away. If you have low blood sugar, follow the instructions you have been given, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:
Irritation at the injection site
* Weight gain
This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of low blood sugar (hypoglycemia): sweating, shaking, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat. Treat immediately with fast-acting sugar.
- Symptoms of high blood sugar (hyperglycemia): increased thirst, frequent urination, fatigue, blurred vision, unexplained weight loss. Contact your doctor if persistent.
- Symptoms of severe allergic reaction: rash, itching, hives, swelling of your face, lips, tongue, or throat, trouble breathing. Seek immediate medical attention.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
If you have low blood sugar (hypoglycemia), as this may affect your treatment.
This medication may interact with other medications or health conditions. Therefore, it is crucial to provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
* Your existing health problems
Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to ensure your safety. It is your responsibility to verify that it is safe to take this medication in combination with your other medications and health conditions.
Precautions & Cautions
Be aware that this medication can cause low blood sugar, which may lead to seizures, loss of consciousness, permanent brain damage, and even death if not properly managed. Consult your doctor to discuss the risks and prevention strategies.
Additionally, this medication can cause low blood potassium levels, which, if left untreated, may result in abnormal heart rhythms, severe breathing difficulties, and potentially death. It is crucial to discuss this risk with your doctor.
If you are taking diabetes medications like pioglitazone or rosiglitazone, be aware that they may increase the risk of heart failure or worsen existing heart failure. Using insulin with these medications may further increase this risk. If you are taking one of these medications, consult your doctor to discuss the potential risks and benefits.
To ensure safe use, verify that you have the correct insulin product and understand how to measure and prepare your dose. Insulin products are available in various containers, including vials, cartridges, and pens. If you have any questions or concerns, contact your doctor or pharmacist.
During times of stress, such as illness, infection, injury, or surgery, it may be more challenging to control your blood sugar levels. Changes in physical activity, exercise, or diet can also impact your blood sugar levels.
For your safety, wear a medical alert identification (ID) that indicates your condition. Avoid driving if you have experienced low blood sugar, as it can increase your risk of being involved in an accident.
Follow your doctor's instructions for monitoring your blood sugar levels and scheduling blood work. Consult your doctor before consuming alcohol or using products that contain alcohol.
Do not share your insulin product or any related devices, including pens, cartridge devices, needles, or syringes, with others, even if the needle has been changed. Sharing can transmit infections, including those you may not be aware of having.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the potential benefits and risks to you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypoglycemia (very low blood sugar)
- Confusion
- Seizures
- Loss of consciousness (coma)
What to Do:
If conscious, administer oral glucose (e.g., glucose tablets, juice, candy). If unconscious, administer glucagon injection and seek immediate medical attention. Call 911 or 1-800-222-1222 (Poison Control Center).
Drug Interactions
Major Interactions
- Beta-blockers (may mask symptoms of hypoglycemia)
- Thiazolidinediones (TZDs) (increased risk of fluid retention and heart failure when used with insulin)
- Corticosteroids (may increase blood glucose, requiring higher insulin doses)
- Diuretics (especially thiazide and loop diuretics, may increase blood glucose)
- Sympathomimetics (e.g., albuterol, epinephrine, may increase blood glucose)
- Atypical antipsychotics (may cause hyperglycemia)
- Protease inhibitors (may cause hyperglycemia)
Moderate Interactions
- Alcohol (may potentiate hypoglycemic effect)
- Salicylates (e.g., aspirin, may enhance insulin's glucose-lowering effect)
- Sulfonamide antibiotics (may enhance insulin's glucose-lowering effect)
- Monoamine Oxidase Inhibitors (MAOIs) (may enhance insulin's glucose-lowering effect)
- Angiotensin-converting enzyme (ACE) inhibitors (may enhance insulin's glucose-lowering effect)
- Somatostatin analogs (e.g., octreotide, may decrease insulin requirements)
- Danazol (may increase insulin requirements)
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and guide initial dosing.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline glucose levels.
Timing: Prior to initiation of therapy.
Rationale: To assess kidney function, as insulin clearance can be affected by renal impairment.
Timing: Prior to initiation and periodically thereafter.
Rationale: To assess liver function, as insulin metabolism can be affected by hepatic impairment.
Timing: Prior to initiation and periodically thereafter.
Routine Monitoring
Frequency: Multiple times daily (e.g., pre-meal, 2 hours post-meal, bedtime, overnight as needed)
Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL post-meal
Action Threshold: Below 70 mg/dL (hypoglycemia) or above target range (hyperglycemia) requiring dose adjustment or intervention.
Frequency: Every 3-6 months
Target: Individualized, typically <7% for most adults
Action Threshold: Above target range, indicating need for therapy adjustment.
Frequency: Daily, ongoing
Target: N/A
Action Threshold: Presence of symptoms (e.g., sweating, tremor, confusion) requires immediate action (glucose intake).
Frequency: With each injection
Target: N/A
Action Threshold: Presence of lipodystrophy, redness, swelling, or pain requires site rotation or medical evaluation.
Symptom Monitoring
- Symptoms of hypoglycemia: sweating, tremor, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat, anxiety, weakness.
- Symptoms of hyperglycemia: increased thirst, increased urination, fatigue, blurred vision, unexplained weight loss, nausea, vomiting, fruity breath odor (ketoacidosis).
- Symptoms of allergic reaction: rash, itching, hives, swelling of face/lips/tongue/throat, difficulty breathing.
Special Patient Groups
Pregnancy
Insulin is the preferred treatment for diabetes in pregnancy. Humalog Mix 50/50 can be used, but careful monitoring and dose adjustment are crucial to maintain strict glycemic control and minimize risks to both mother and fetus. The FDA's new pregnancy labeling (PLLR) for insulin lispro states that available data from published studies on insulin lispro use in pregnant women have not reported an association with major birth defects, miscarriage, or adverse maternal or fetal outcomes.
Trimester-Specific Risks:
Lactation
Insulin is compatible with breastfeeding. Insulin is a normal component of human milk and is not orally absorbed by the infant. No adverse effects on the breastfed infant are expected. Insulin requirements may decrease during lactation, especially in the immediate postpartum period.
Pediatric Use
Humalog Mix 50/50 is approved for use in pediatric patients with diabetes. Dosing must be highly individualized and carefully monitored due to varying insulin sensitivity and growth patterns. Risk of hypoglycemia may be higher in younger children.
Geriatric Use
Use with caution in elderly patients due to increased risk of hypoglycemia, particularly in those with renal or hepatic impairment. Start with lower doses and titrate slowly. Monitor blood glucose levels more frequently and educate on hypoglycemia symptoms.
Clinical Information
Clinical Pearls
- Always inspect the vial for particulate matter or discoloration before use. Humalog Mix 50/50 should appear uniformly cloudy after resuspension.
- Gently roll the vial between the palms 10 times and invert 10 times immediately before each injection to ensure the insulin is thoroughly mixed.
- Administer Humalog Mix 50/50 subcutaneously into the abdomen, thigh, upper arm, or buttocks. Rotate injection sites within the same region to reduce the risk of lipodystrophy.
- This product is a fixed combination; it cannot be adjusted for individual rapid-acting or intermediate-acting needs separately. If a patient's needs for rapid-acting and intermediate-acting insulin differ significantly, separate insulin products may be more appropriate.
- Never share insulin pens or syringes between patients, even if the needle is changed, due to the risk of blood-borne pathogen transmission.
- Store unopened vials in the refrigerator (2°C to 8°C [36°F to 46°F]). Once opened, store at room temperature (below 30°C [86°F]) and discard after 28 days.
Alternative Therapies
- Basal-bolus insulin regimens (e.g., long-acting insulin + rapid-acting insulin)
- Basal insulin only (e.g., Insulin Glargine, Insulin Detemir, Insulin Degludec)
- Rapid-acting insulin only (e.g., Insulin Lispro, Insulin Aspart, Insulin Glulisine)
- Oral antidiabetic agents (e.g., Metformin, Sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists)